| Type | Title | Date Released | |
|---|---|---|---|
8-K | Resignation of BridgeBio Oncology Therapeutics' Chief Medical and Development Officer | ||
4 | Cobo Marc (Reporting) | ||
4 | Cobo Marc (Reporting) | ||
4 | Elmelech Idan (Reporting) | ||
4 | Beltran Pedro (Reporting) | ||
4 | Ben Yong (Reporting) | ||
4 | Cobo Marc (Reporting) | ||
EFFECT | Form EFFECT | ||
EFFECT | Form EFFECT | ||
8-K | BridgeBio Oncology Therapeutics Announces New BBO-8520 Clinical Data and Strategic Pipeline Prioritization | ||
S-3 | September 2026 SHELF + ATM | ||
POS AM | SHARE RESALE REGISTRATION | Shares: 63,054,549 EFFECTIVE, DATED 2026-09-08 |
